Primary |
Drug Use For Unknown Indication |
28.4% |
Spinal Anaesthesia |
21.6% |
Pain |
14.0% |
Analgesia |
7.2% |
Analgesic Therapy |
3.8% |
Back Pain |
3.4% |
Anaesthesia |
2.3% |
Cardiac Failure Congestive |
2.3% |
Pain Management |
2.3% |
Abdominal Pain |
1.9% |
Product Used For Unknown Indication |
1.9% |
Drug Abuse |
1.5% |
Suicide Attempt |
1.5% |
Surgery |
1.5% |
Antibiotic Therapy |
1.1% |
Cancer Pain |
1.1% |
Musculoskeletal Pain |
1.1% |
Postoperative Analgesia |
1.1% |
Stem Cell Transplant |
1.1% |
Constipation |
0.8% |
|
Hypotension |
22.2% |
Overdose |
8.6% |
Unresponsive To Stimuli |
8.6% |
Death |
7.4% |
Procedural Hypotension |
7.4% |
Somnolence |
4.9% |
Therapeutic Agent Toxicity |
4.9% |
Incorrect Dose Administered |
3.7% |
Malaise |
3.7% |
Respiratory Arrest |
3.7% |
Hyperkalaemia |
2.5% |
Hypogonadism |
2.5% |
Infusion Site Mass |
2.5% |
Obstetric Procedure Complication |
2.5% |
Pneumonia Aspiration |
2.5% |
Respiratory Depression |
2.5% |
Retching |
2.5% |
Sedation |
2.5% |
Sensory Loss |
2.5% |
Staphylococcal Infection |
2.5% |
|
Secondary |
Drug Use For Unknown Indication |
35.9% |
Product Used For Unknown Indication |
16.6% |
Pain |
6.9% |
Back Pain |
5.9% |
Analgesic Therapy |
5.0% |
Cancer Pain |
4.5% |
Procedural Pain |
3.5% |
Anaesthesia |
3.1% |
Maintenance Of Anaesthesia |
3.1% |
Neuralgia |
3.1% |
Myelitis Transverse |
2.1% |
Major Depression |
1.4% |
Analgesia |
1.2% |
Drug Abuse |
1.2% |
Pain Management |
1.2% |
Vomiting |
1.2% |
General Anaesthesia |
1.0% |
Nausea |
1.0% |
Pancreatic Carcinoma Metastatic |
1.0% |
Hypertension |
0.9% |
|
Drug Toxicity |
16.8% |
Death |
13.7% |
Cardio-respiratory Arrest |
9.5% |
Therapeutic Agent Toxicity |
7.4% |
Overdose |
5.3% |
Vomiting |
5.3% |
Drug Withdrawal Syndrome |
4.2% |
Pneumonia Aspiration |
4.2% |
Post Procedural Haemorrhage |
4.2% |
Swelling |
4.2% |
White Blood Cell Count Increased |
4.2% |
Catatonia |
3.2% |
Suicide Attempt |
3.2% |
Unresponsive To Stimuli |
3.2% |
Cellulitis |
2.1% |
Hyperaesthesia |
2.1% |
Pleural Effusion |
2.1% |
Self-injurious Ideation |
2.1% |
Somnolence |
2.1% |
Acute Generalised Exanthematous Pustulosis |
1.1% |
|
Concomitant |
Drug Use For Unknown Indication |
19.5% |
Pain |
13.2% |
Prophylaxis |
9.1% |
Multiple Myeloma |
6.9% |
Rheumatoid Arthritis |
5.7% |
Abdominal Pain |
5.1% |
Prophylaxis Of Nausea And Vomiting |
4.0% |
Crohn's Disease |
3.8% |
Insomnia |
3.5% |
Non-small Cell Lung Cancer |
3.3% |
Acute Myeloid Leukaemia |
3.2% |
Pancreatic Carcinoma |
3.2% |
Prostate Cancer Stage Iv |
3.0% |
Menopause |
2.6% |
Neutropenia |
2.6% |
Rash |
2.6% |
Cancer Pain |
2.4% |
Hypertension |
2.4% |
Liver Transplant |
2.1% |
Lung Neoplasm Malignant |
1.9% |
|
Vomiting |
9.8% |
Acute Myeloid Leukaemia |
8.8% |
Urinary Tract Infection |
7.8% |
Respiratory Failure |
6.9% |
Somnolence |
6.9% |
Weight Decreased |
6.9% |
Thrombocytopenia |
5.9% |
White Blood Cell Count Decreased |
5.9% |
Pain |
4.9% |
Death |
3.9% |
Incorrect Dose Administered |
3.9% |
Pneumonia |
3.9% |
Wrong Technique In Drug Usage Process |
3.9% |
Epilepsy |
2.9% |
Jaundice Cholestatic |
2.9% |
Oedema Peripheral |
2.9% |
Oesophagitis |
2.9% |
Pancreatitis Acute |
2.9% |
Pruritus |
2.9% |
Type 2 Diabetes Mellitus |
2.9% |
|
Interacting |
Pain |
50.0% |
Product Used For Unknown Indication |
50.0% |
|
Inhibitory Drug Interaction |
100.0% |
|